Warburg Pincus Aur Maneesh Pharma: ₹1800 Cr Ki Deal Final Hone Ke Kareeb!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Warburg Pincus Aur Maneesh Pharma: ₹1800 Cr Ki Deal Final Hone Ke Kareeb!
Overview

US ki badi private equity firm Warburg Pincus, Maneesh Pharma ke non-TB medicine brands ko kharidne ke bilkul kareeb pahunch gayi hai. Ye deal around **₹1,800 crore** ki ho sakti hai, jismein pharma ke achhe-achhe brands shamil hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Deal Final Stages Mein Hai!

Yaar, ye deal 2 saal se chal rahi thi aur ab lagta hai ki finally finalize hone wali hai. Sunne mein aa raha hai ki exclusivity agreement bhi ho gaya hai. Warburg Pincus, Maneesh Pharma ke non-tuberculosis (non-TB) wale medicines ka portfolio ₹1,600 crore se lekar ₹1,800 crore tak mein acquire karne ke liye ready hai.

Maneesh Ke Brands Hain Zabardast!

Maneesh Pharma ke paas kuch bahut hi solid brands hain, jaise Smyle Mouth Ulcer Gel aur gynaecology ke liye Doxinate aur Clofert. Sirf Doxinate, jo morning sickness ke liye use hota hai, uski sales hi saal mein ₹110 crore ke aas paas hai! Company ka moving annual turnover February 2026 tak ₹504 crore tha, jo ki 6% growth rate dikha raha tha.

Warburg Ka Bada Plan Hai India Mein

Ye acquisition Warburg Pincus ke ek bade plan ka hissa hai. Wo India mein 2 se 3 pharma companies ko milakar ek bada business platform banana chahte hain. Iske liye wo ek experienced leader bhi dhoondh rahe hain. Aisi khabrein hain ki Merck & Co. India ke ex-head Rehan Khan ko bhi is role ke liye consider kiya ja sakta hai. Pichli baar Warburg ne ₹1,200 crore mein Integrace Health kharidne ki koshish ki thi, jisse pata chalta hai ki ye log Indian healthcare sector mein kaafi serious hain.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.